ARTICLE
10 February 2026

US Policy Is Disrupting The Global Pharmaceutical Industry

As recent US drug-pricing policy proposals prompt pharmaceutical companies to disclose European price benchmarks, questions are emerging around how these measures may influence market strategy.
Worldwide Food, Drugs, Healthcare, Life Sciences
Emmanuelle Trombe’s articles from McDermott Will & Schulte are most popular:
  • within Food, Drugs, Healthcare and Life Sciences topic(s)
  • in United Kingdom
McDermott Will & Schulte are most popular:
  • within Food, Drugs, Healthcare, Life Sciences, Cannabis & Hemp and Privacy topic(s)

As recent US drug-pricing policy proposals prompt pharmaceutical companies to disclose European price benchmarks, questions are emerging around how these measures may influence market strategy.

According to partner Emmanuelle Trombe in an interview with Le Figaro, some companies may reconsider whether to launch new innovations in Europe as a result.

Click here to access the full article (in French) via paywall.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More